Exploration of new molecular mechanisms for antidepressant actions of electroconvulsive seizure

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 7, 2011, Pages 939-944

  Segi Nishida, Eri ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antidepressant; Cyclooxygenase; Electroconvulsive seizure; Gene expression; Hippocampus; Neurogenesis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; NEUROPEPTIDE Y; PROSTANOID; VASCULOTROPIN;

BEHAVIOR CHANGE; BRAIN REGION; CELL ACTIVITY; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL EFFECTIVENESS; CYCLOOXYGENASE 2 GENE; DENTATE GYRUS; DEPRESSION; ELECTROCONVULSIVE THERAPY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; GENE CONTROL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMAN; NERVE CELL STIMULATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PREFRONTAL CORTEX; PROTEIN FUNCTION; REGULATOR GENE; REVIEW; STRUCTURE ACTIVITY RELATION; THERAPY EFFECT;

CYCLOOXYGENASE 2; ELECTROCONVULSIVE THERAPY; HIPPOCAMPUS; HUMANS; NEUROGENESIS; SEIZURES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960308926     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.939     Document Type: Review

References (58)

1. Kessler R. C., McGonagle K. A., Zhao S., Nelson C. B., Hughes M., Eshleman S., Wittchen H. U., Kendler K. S., Arch. Gen. Psychiatry, 51, 8-19 (1994).
2. Nelson J. C., Biol. Psychiatry, 46, 1301-1308 (1999).
3. The U. K. ECT Review Group, Lancet, 361, 799-808 (2003).
4. Pagnin D., de Queiroz V., Pini S., Cassano G. B., J. ECT, 20, 13-20 (2004).
5. Tanis K. Q., Duman R. S., Ann. Med., 39, 531-544 (2007).
6. Coyle J. T., Duman R. S., Neuron, 38, 157-160 (2003).
7. Duman R. S., Vaidya V. A., J. ECT, 14, 181-193 (1998).
8. Nibuya M., Morinobu S., Duman R. S., J. Neurosci., 15, 7539-7547 (1995).
9. Newton S. S., Collier E. F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., Duman R. S., J. Neurosci., 23, 10841-10851 (2003).
10. Altar C. A., Laeng P., Jurata L. W., Brockman J. A., Lemire A., Bullard J., Bukhman Y. V., Young T. A., Charles V., Palfreyman M. G., J. Neurosci., 24, 2667-2677 (2004).
11. Warner-Schmidt J. L., Duman R. S., Proc. Natl. Acad. Sci. U.S.A., 104, 4647-4652 (2007).
12. Schmidt H. D., Duman R. S., Behav. Pharmacol., 18, 391-418 (2007).
13. Shirayama Y., Chen A. C., Nakagawa S., Russell D. S., Duman R. S., J. Neurosci., 22, 3251-3261 (2002).
14. Redrobe J. P., Dumont Y., Fournier A., Quirion R., Neuropsychopharmacology, 26, 615-624 (2002).
15. Ishida H., Shirayama Y., Iwata M., Katayama S., Yamamoto A., Kawahara R., Nakagome K., Hippocampus, 17, 271-280 (2007).
16. Pekary A. E., Meyerhoff J. L., Sattin A., Brain Res., 884, 174-183 (2000).
17. Levi A., Ferri G. L., Watson E., Possenti R., Salton S. R., Cell. Mol. Neurobiol., 24, 517-533 (2004).
18. Levi A., Eldridge J. D., Paterson B. M., Science, 229, 393-395 (1985).
19. Hunsberger J. G., Newton S. S., Bennett A. H., Duman C. H., Russell D. S., Salton S. R., Duman R. S., Nat. Med., 13, 1476-1482 (2007).
20. Thakker-Varia S., Krol J. J., Nettleton J., Bilimoria P. M., Bangasser D. A., Shors T. J., Black I. B., Alder J., J. Neurosci., 27, 12156-12167 (2007).
21. Duman R. S., Biol. Psychiatry, 56, 140-145 (2004).
22. Warner-Schmidt J. L., Duman R. S., Hippocampus, 16, 239-249 (2006).
23. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R., Science, 301, 805-809 (2003).
24. Malberg J. E., Eisch A. J., Nestler E. J., Duman R. S., J. Neurosci., 20, 9104-9110 (2000).
25. Segi-Nishida E., Warner-Schmidt J. L., Duman R. S., Proc. Natl. Acad. Sci. U.S.A., 105, 11352-11357 (2008).
26. Encinas J. M., Vaahtokari A., Enikolopov G., Proc. Natl. Acad. Sci. U.S.A., 103, 8233-8238 (2006).
27. Warner-Schmidt J. L., Duman R. S., Proc. Natl. Acad. Sci. U.S.A., 104, 4647-4652 (2007).
28. Sairanen M., Lucas G., Ernfors P., Castrén M., Castrén E., J. Neurosci., 25, 1089-1094 (2005).
29. Vaidya V. A., Siuciak J. A., Du F., Duman R. S., Neuroscience, 89, 157-166 (1999).
30. Lamont S. R., Paulls A., Stewart C. A., Brain Res., 893, 53-58 (2001).
31. Weeks D., Freeman C. P., Kendell R. E., Br. J. Psychiatry, 137, 26-37 (1980).
32. Stewart C., Jeffery K., Reid I., Neuroreport, 5, 1041-1044 (1994).
33. Stewart C. A., Reid I. C., Psychopharmacology, 148, 217-223 (2000).
34. Kobayashi K., Ikeda Y., Sakai A., Yamasaki N., Haneda E., Miyakawa T., Suzuki H., Proc. Natl. Acad. Sci. U.S.A., 107, 8434-8439 (2010).
35. Wang J. W., David D. J., Monckton J. E., Battaglia F., Hen R., J. Neurosci., 28, 1374-1384 (2008).
36. Yamagata K., Andreasson K. I., Kaufmann W. E., Barnes C. A., Worley P. F., Neuron, 11, 371-386 (1993).
37. Kaufmann W. E., Worley P. F., Pegg J., Bremer M., Isakson P., Proc. Natl. Acad. Sci. U.S.A., 93, 2317-2321 (1996).
38. Ohtsuki T., Kitagawa K., Yamagata K., Mandai K., Mabuchi T., Matsushita K., Yanagihara T., Matsumoto M., Brain Res., 736, 353-356 (1996).
39. Andrade C., Singh N. M., Thyagarajan S., Nagaraja N., Sanjay Kumar Rao N., Suresh Chandra J., J. Psychiatr. Res., 42, 837-850 (2008).
40. Rall J. M., Mach S. A., Dash P. K., Brain Res., 968, 273-276 (2003).
41. Yang H., Zhang J., Breyer R. M., Chen C., J. Neurochem., 108, 295-304 (2009).
42. Chen J., Marsh T., Zhang J. S., Graham S. H., Neuroreport, 6, 245-248 (1995).
43. Baik E. J., Kim E. J., Lee S. H., Moon C., Brain Res., 843, 118-129 (1999).
44. Kunz T., Oliw E. H., Eur. J. Neurosci., 13, 569-575 (2001).
45. Uchida K., Kumihashi K., Kurosawa S., Kobayashi T., Itoi K., Machida T., Zoolog. Sci., 19, 1211-1216 (2002).
46. Sasaki T., Kitagawa K., Sugiura S., Omura-Matsuoka E., Tanaka S., Yagita Y., Okano H., Matsumoto M., Hori M., J. Neurosci. Res., 72, 461-471 (2003).
47. Kumihashi K., Uchida K., Miyazaki H., Kobayashi J., Tsushima T., Machida T., Neuroreport, 12, 915-917 (2001).
48. Koo J. W., Duman R. S., Curr. Opin. Investig. Drugs, 10, 664-671 (2009).
49. Caggiano A. O., Kraig R. P., J. Neurochem., 72, 565-575 (1999).
50. Madsen T. M., Yeh D. D., Valentine G. W., Duman R. S., Neuropsychopharmacology, 30, 27-34 (2005).
51. Jansson L., Hellsten J., Tingström A., Biol. Psychiatry, 60, 874-881 (2006).
52. Wennström M., Hellsten J., Tingström A., Biol. Psychiatry, 55, 464-471 (2004).
53. D'Costa A., Breese C. R., Boyd R. L., Booze R. M., Sonntag W. E., Brain Res., 567, 204-211 (1991).
54. Conti B., Maier R., Barr A. M., Morale M. C., Lu X., Sanna P. P., Bilbe G., Hoyer D., Bartfai T., Mol. Psychiatry, 12, 167-189 (2007).
55. Porsolt R. D., Anton G., Blavet N., Jalfre M., Eur. J. Pharmacol., 47, 379-391 (1978).
56. Christiansen S. H., Woldbye D. P., J. Neurosci. Res., 88, 3635-3643 (2010).
57. Hageman I., Nielsen M., Wortwein G., Diemer N. H., Jorgensen M. B., Behav. Brain Res., 196, 71-77 (2009).
58. Li B., Suemaru K., Cui R., Kitamura Y., Gomita Y., Araki H., Eur. J. Pharmacol., 529, 114-121 (2006).